Indian breast cancer therapeutics market is estimated to grow significantly at a CAGR of around 10.7% during the forecast period. The major factors that drive the market include the high prevalence of breast cancer, awareness programs by government and private organizations. Government agencies, NGOs and charity organizations have put great emphasis on improved breast cancer awareness among masses for promotion of early detection, providing comprehensive treatment module, providing support for breast cancer management and rehabilitation. The introduction of project Extension for Community Healthcare Outcomes (ECHO) by organizing breast cancer awareness and screening programs for rural and semi-urban Indian population. This project increased the cancer literacy amongst the rural population and awareness on early diagnosis of breast cancers and more public facilities for breast cancer treatments.
To Request a Sample of our Report on Indian Breast Cancer Therapeutics Market: https://www.omrglobal.com/request-sample/indian-breast-cancer-therapeutics-market
Indian breast cancer therapeutics market is segmented on the basis of therapy. The therapy segment is further classified into chemotherapy, hormone therapy, targeted therapy, radiation therapy and others (surgery). Among all therapies, chemotherapy market held the largest market share in the Indian breast cancer therapeutics market. Chemotherapy is most used when cancer in the lymph nodes and irrespective of tumor size or menopausal status. Along with that it is used for the treatment of breast cancer in premenopausal women and referred for those women who diagnosed with early stage breast cancer for hormone receptor negative and HER2 positive cancer. The types of chemotherapy include adjuvant chemotherapy and neoadjuvant chemotherapy. The adjuvant chemotherapy is used to destroy cancer cells that have been spread and not seen by the imaging tests. This method helps in reducing the cancer cells that form a new tumor in the other place of the body. Adjuvant chemotherapy reduces the risk of breast cancer coming back. Neoadjuvant chemotherapy can be used to reduce the size of the tumor, so it can be removed with less widespread surgery.
(Get 15% Discount on Buying this Report)
A full Report of Indian Breast Cancer Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/indian-breast-cancer-therapeutics-market
Indian Breast Cancer Therapeutics Market Segmentation
By Therapy
- Chemotherapy
- Hormone Therapy
- Targeted Therapy
- Radiation Therapy
- Others (Surgery)
Company Profiles
- AbbVie Inc.
- AstraZeneca PLC
- Eisai Co., Ltd
- GlaxoSmithKline PLC
- Merck & Co., Inc.
- Novartis International AG
- F. Hoffmann-La Roche AG
- Pfizer Inc.
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
